Synvect
Latest round
- Seed
Last raised
- Mar 2025
Total raised
- $3M
Investors
- 4
About Synvect
Founded in 2022 and based in California, US, Synvect, Inc. operates as a bioengineering platform that eradicates mosquito-borne diseases. The company was founded by its CEO, Nikolay Kandul, CSO Omar Akbari, and Ravi Solanki. In September 2024, Synvect, Inc. Synvect offers CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene editing technology to sterilize male mosquitoes. The company’s primary product includes a genetically engineered mosquito that, when released into the environment, mates with wild females. These matings result in sterile eggs, leading to a reduction in the overall mosquito population.
Who invested in Synvect
4 investors across 1 round
See all investors in Synvect
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 11, 2025
Amount
$3M
Investors
Questions about Synvect
Who invested in Synvect?
Synvect has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synvect raised?
Synvect has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Synvect last raise money?
Synvect's most recent round on record is a Seed, in Mar 2025.
What does Synvect do?
Founded in 2022 and based in California, US, Synvect, Inc.
Where is Synvect headquartered?
Synvect is headquartered in San Diego, US.
Which VCs invest in companies like Synvect?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synvect's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Synvect? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.